YCC 13 |
| The biotechnology sector is a vibrant, innovation-driven and successful component of the chemical enterprise. A confluence of spectacular advances in chemistry, molecular biology and genomics has led to the discovery and development of numerous therapies and technologies. Priority is the integration of discovery technologies, chemical development, and refined deployment of information technologies. The entrepreneurial industry has established global strategic partnerships. Rapid pace of regulatory reform allied with the necessity of effecting drastic reductions in costs has resulted in marked shifts in strategic paradigms. A highly trained and motivated work force, political stability, and research skills of the chemists has resulted in significant strategic sourcing overseas. Innovation is global and scientists should not hesitate to accept overseas assignments. It is important to adjust to certain cultural parameters but the adventure is well worth the risk. New opportunities exist for chemists in business development, regulatory affairs, project management, management of strategic alliances. |
|
Changing Landscapes of the Bio-Pharma Industry
9:00 AM-11:10 AM, Tuesday, August 21, 2007 Sheraton Boston -- Republic A, Oral
Younger Chemists Committee |